USPatent applicationPatented

Cyclohexene compounds for liquid-crystalline mixtures

Granted 24 Apr 2012 · 3 office actions

Life of the application

12 dated events
⤢ drag to zoom20082010201220142016201820202022202420262028ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

The invention relates to liquid-crystalline compounds of the formula I [structure] in which R 1 , R 2 , A 1 , A 2 , A 3 , A 4 , Z 1 , Z 2 , Z 3 , V, a, b and c have the meanings indicated in Claim 1 , and to liquid-crystalline media comprising at least one compound of the formula I, and to electro-optical displays containing a liquid-crystalline medium of this type.

Description

29 parts
›The invention relates to 1,4-substituted cyclohexene derivatives and…

The invention relates to 1,4-substituted cyclohexene derivatives and 2-fluorocyclohexene derivatives and to the use thereof as component(s) in liquid-crystalline media. In addition, the present invention relates to liquid-crystal and electro-optical display elements which contain the liquid-crystalline media according to the invention. The compounds according to the invention contain a difluoromethyleneoxy group in a certain arrangement.

In the preceding years, the areas of application of liquid-crystalline compounds have been considerably broadened to various types of display device, electro-optical devices, electronic components, sensors, etc. For this reason, a number of different structures have been proposed, in particular in the area of nematic liquid crystals. The nematic liquid-crystal mixtures have to date found the broadest application in flat display devices. They have been employed, in particular, in passive TN or STN matrix displays or systems having a TFT active matrix.

The liquid-crystalline compounds according to the invention can be used as component(s) of liquid-crystalline media, in particular for displays based on the principle of the twisted cell, the guest-host effect, the effect of deformation of aligned phases DAP or ECB (electrically controlled birefringence), the IPS (in-plane switching) effect or the effect of dynamic scattering.

The use of certain derivatives containing a difluoromethyleneoxy bridge (—CF 2 O—) as liquid-crystalline substances is known to the person skilled in the art. The publication EP 844229 A1 discloses substances containing a cyclohexene ring and a CF 2 O group. However, the double bond of the cyclohexene ring in the compounds is connected directly to the difluoromethylene unit of the CF 2 O group. The publication EP 1482018 A1 discloses a substance containing a cyclohexene ring and a CF 2 O group as synthetic intermediate which is not purified or characterised. The compound has a terminal ethyl ester group for the further chemical reaction.

In addition, various compounds containing a difluoromethyleneoxy bridge and no cyclohexene ring have already been described as liquid-crystalline material, as has the preparation thereof, such as, for example, in the publication EP 0786445 A1.

The present invention had the object of finding novel stable liquid-crystalline or mesogenic compounds which are suitable as component(s) of liquid-crystalline media. In particular, the compounds should simultaneously have comparatively low viscosity and a dielectric anisotropy in the positive region. For many current mixture concepts in the area of liquid crystals, it is advantageous to use compounds having high dielectric anisotropy Δ∈.

In view of the very wide variety of areas of application of compounds of this type having high Δ∈, it was desirable to have available further compounds, preferably having high nematogeneity, which have properties which are precisely customised to the particular applications.

It was thus an object of the invention to find novel stable liquid-crystalline or mesogenic compounds which are suitable as component(s) of liquid-crystalline media, in particular for, for example, TN, STN, IPS and TN-TFT displays.

It was a further object of the present invention to provide liquid-crystalline or mesogenic compounds which have, per se or in mixtures, high dielectric anisotropy Δ∈, a high clearing point and low rotational viscosity γ 1 . In addition, the compounds according to the invention should be thermally and photochemically stable under the conditions prevailing in the areas of application. Furthermore, the compounds according to the invention should as far as possible have a broad nematic phase. As mesogens, they should facilitate a broad nematic phase in mixtures with liquid-crystalline co-components and have excellent miscibility with nematic base mixtures, in particular at low temperatures. Preference is likewise given to substances having a low melting point and a low enthalpy of melting since these quantities are in turn a sign of the desirable properties mentioned above, such as, for example, high solubility and a broad liquid-crystalline phase, etc.

Surprisingly, it has been found that the cyclohexene derivatives according to the invention are eminently suitable as components of liquid-crystalline media. They can be used to obtain liquid-crystalline media, particularly suitable for TN-TFT and STN displays, but also for IPS systems or more recent concepts which require particularly high dielectric anisotropies. The compounds according to the invention have adequate stability and are colourless. They are also distinguished by strongly positive dielectric anisotropies Δ∈, due to which lower threshold voltages are required on use in optical switching elements. They have a particularly broad nematic phase range. In addition, the compounds according to the invention have a high clearing point and at the same time low values for the rotational viscosity. Compared with substances from the prior art, significantly lower melting points and enthalpies of melting are observed.

The provision of the cyclohexene derivatives according to the invention very generally considerably broadens the range of liquid-crystalline substances which are suitable, from various applicational points of view, for the preparation of liquid-crystalline mixtures.

The cyclohexene derivatives according to the invention have a broad range of applications. Depending on the choice of substituents, these compounds can serve as base materials of which liquid-crystalline media are predominantly composed. However, it is also possible to add liquid-crystalline base materials from other classes of compound to the compounds according to the invention in order, for example, to modify the dielectric and/or optical anisotropy of a dielectric of this type and/or to optimise its threshold voltage and/or its viscosity.

The invention thus relates to compounds of the formula I

in which

R 1 and R 2 each, independently of one another, denote H, F, Cl, Br, a halogenated or unsubstituted alkyl radical having 1 to 15 C atoms, where one or more CH 2 groups in these radicals may also each be replaced, independently of one another, by —C≡C—, —CH═CH—, —(CO)O—, —O(CO)—, —(CO)— or —O— in such a way that O atoms are not linked directly to one another, where R 2 may also denote CN, SCN, NCS or SF 5 ,

›with the proviso that R 1 is not…

with the proviso that R 1 is not an ester group of the formula —(CO)O—C 2 H 5 , in particular not of the formula —(CO)O-alkyl,

A 1 , A 2 , A 3 and A 4 each, independently of one another, identically or differently, denote: a) trans-1,4-cyclohexylene or cyclohexenylene, in which, in addition, one or more non-adjacent CH 2 groups may be replaced by —O— and/or —S— and in which H may be substituted by F, b) 1,4-phenylene, in which one or two CH groups may be replaced by N and in which, in addition, one or more H atoms may be replaced by Br, Cl, F, CN, methyl, methoxy or a mono- or polyfluorinated methyl or methoxy group, or c) a radical from the group 1,4-bicyclo[2.2.2]octylene, piperidine-1,4-diyl, cyclobutane-1,3-diyl, spiro[3.3]heptane-2,6-diyl,

where a+b+c is ≦4.

A 1-3 and Z 1-3 can also independently adopt different meanings if they occur a number of times for a, b or c>1.

The invention furthermore relates to the use of the compounds of the formula I in liquid-crystalline media.

The present invention likewise relates to liquid-crystalline media having at least two liquid-crystalline components which comprise at least one cyclohexene derivative of the formula I.

The compounds of the formula I have a broad range of applications. Depending on the choice of substituents, these compounds can serve as base materials of which liquid-crystalline media are predominantly composed; however, it is also possible to add liquid-crystalline base materials from other classes of compound to compounds of the formula I in order, for example, to modify the dielectric and/or optical anisotropy of a dielectric of this type and/or to optimise its threshold voltage and/or its viscosity.

In the pure state, the compounds of the formula I are colourless and form, per se or in mixtures, liquid-crystalline mesophases in a temperature range which is favourably located for electro-optical use. The compounds according to the invention enable broad nematic phase ranges to be achieved. In liquid-crystalline mixtures, the substances according to the invention suppress smectic phases and result in a significant improvement in the low-temperature storage stability.

Preference is given to compounds of the formula I in which a is 0 or 1, in particular a=1.

Z 1 and/or Z 3 preferably denote a single bond, —CF 2 O—, —OCF 2 —, —C 2 F 4 —, —CH 2 O—, —OCH 2 — or —(CO)O—, in particular a single bond. Z 2 preferably denotes —CH 2 CH 2 —, —CH═CH—, —C≡C— or a single bond, in particular a single bond.

In the case where Z 2 is a single bond, A 2 preferably denotes an unsaturated or aromatic ring from group b) or c) according to the definition of formula I. In this case, the double bond of the cyclohexene is conjugated with the adjacent unsaturated ring A 2 .

A 1 , A 2 , A 3 and A 4 preferably denote

and furthermore

A 2 preferably denotes

A 4 preferably denotes

R 1 preferably denotes alkyl, alkoxy, alkenyl or alkenyloxy having up to 8 carbon atoms. R 1 particularly preferably denotes straight-chain alkyl or alkenyl.

R 2 preferably denotes X, where

X denotes F, Cl, OCF 3 , OCHF 2 , OCHFCF 3 , OCF 2 CHFCF 3 , CF 3 , CN, SF 5 , NCS, in particular F, Cl, CN or OCF 3 and very particularly F.

R 1 and R 2 preferably do not simultaneously denote H.

Particular preference is given to compounds of the formula IA

in which

R 1 , A 1 , X, a, b and V have the meanings indicated above for formula I, and L 1 , L 2 , L 3 and L 4 denote H or F.

Preference is given to compounds of the formula IA in which L 1 denotes fluorine. b preferably denotes 1. V is preferably H. L 3 is preferably F.

Particularly preferred compounds of the formula I are the compounds of the formulae I1 to I5

in which R 1 , V and X have the meanings indicated above. L 2 , L 3 , L 4 , L 6 and L 6 , independently of one another, denote H or F.

In the case of compounds which can occur in diastereomers, both the pure substances and also any mixing ratio of the isomers are covered and in each case are to be regarded as suitable mixture component.

The compounds of the formula I are prepared by methods known per se, as described in the literature (for example in the standard works, such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart), to be precise under reaction conditions which are known and suitable for the said reactions. Use can also be made here of variants known per se which are not mentioned here in greater detail.

The compounds of the formula I can advantageously be prepared as evident from the following illustrative syntheses (schemes 1 and 2):

The moieties here have the following meanings:

The groups of the formulae in schemes 1 and 2 which are not involved can be varied so long as the compounds of the formula I suggest it. Corresponding starting materials can generally be prepared readily by the person skilled in the art. In general terms, the compounds of the formulae I and IA can be prepared in this way.

The invention therefore also relates to two process variants for the preparation of compounds of the formula I:

a) A process for the preparation of compounds of the formula I in which V denotes hydrogen comprising a process step, characterised in that a cyclohexane ketone of the formula

in which R 1 , A 1 , Z 1 and a are as defined in Claim 1 ,

is reacted with an organomagnesium compound of the formula

HalMg—(Z 2 -A 2 ) b -CF 2 O-(A 3 -Z 3 ) c -A 4 -R 2

—CH 2 —(CH 2 ) p —CH 2 — and —C(CH 3 ) 2 C(CH 3 ) 2 —,

or 1,2-phenylene, where R 1 , R 2 and R 1 +R 2 may also be substituted and where p is 0 or 1,

in the presence of a transition-metal catalyst, preferably a palladium complex. The complex is preferably bis(triphenylphosphine)palladium(II) chloride.

Compounds according to the invention in which A 2 denotes an optionally substituted 1,4-phenylene and b has the value 2 are advantageously prepared analogously in accordance with scheme 3.

Further preferred process variants are revealed by the examples.

The invention also relates to liquid-crystalline media comprising one or more of the compounds of the formula I according to the invention. The liquid-crystalline media comprise at least two components. They are preferably obtained by mixing the components with one another. A process according to the invention for the preparation of a liquid-crystalline medium is therefore characterised in that at least one compound of the formula I is mixed with at least one further mesogenic compound, and additives are optionally added.

›The achievable combinations of clearing point, viscosity at…

The achievable combinations of clearing point, viscosity at low temperature, thermal and UV stability and dielectric anisotropy are far superior to previous materials from the prior art.

The liquid-crystalline media according to the invention preferably comprise 2 to 40, particularly preferably 4 to 30, components as further constituents besides one or more compounds according to the invention. In particular, these media comprise 7 to 25 components besides one or more compounds according to the invention. These further constituents are preferably selected from nematic or nematogenic (monotropic or isotropic) substances, in particular substances from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl esters of cyclohexanecarboxylic acid, phenyl or cyclohexyl esters of cyclohexylbenzoic acid, phenyl or cyclohexyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexylphenyl esters of benzoic acid, of cyclehexanecarboxylic acid or of cyclohexylcyclohexanecarboxylic acid, phenylcyclohexanes, cyclohexylbiphenyls, phenylcyclohexylcyclohexanes, cyclohexylcyclohexanes, cyclohexylcyclohexylcyclohexanes, 1,4-biscyclohexylbenzenes, 4,4′-biscyclohexylbiphenyls, phenyl- or cyclohexylpyrimidines, phenyl- or cyclohexylpyridines, phenyl- or cyclohexyldioxanes, phenyl- or cyclohexyl-1,3-dithianes, 1,2-diphenylethanes, 1,2-dicyclohexylethanes, 1-phenyl-2-cyclohexylethanes, 1-cyclohexyl-2-(4-phenylcyclohexyl)ethanes, 1-cyclohexyl-2-biphenylethanes, 1-phenyl-2-cyclohexylphenylethanes, optionally halogenated stilbenes, benzyl phenyl ethers, tolans and substituted cinnamic acids. The 1,4-phenylene groups in these compounds may also be fluorinated.

The most important compounds suitable as further constituents of the media according to the invention can be characterised by the formulae 1, 2, 3, 4 and 5:

R′-L-E-R″  1

R′-L-COO-E-R″  2

R′-L-CF 2 O-E-R″  3

R′-L-CH 2 CH 2 -E-R″  4

R′-L-C≡C-E-R″  5

In the formulae 1, 2, 3, 4 and 5, L and E, which may be identical or different, each, independently of one another, denote a divalent radical from the group formed by -Phe-, -Cyc-, -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -Pyr-, -Dio-, -Py-, -G-Phe- and -G-Cyc- and their mirror images, where Phe denotes unsubstituted or fluorine-substituted 1,4-phenylene, Cyc denotes trans-1,4-cyclohexylene, Pyr denotes pyrimidine-2,5-diyl or pyridine-2,5-diyl, Dio denotes 1,3-dioxane-2,5-diyl, Py denotes tetrahydropyran-2,5-diyl and G denotes 2-(trans-1,4-cyclohexyl)ethyl.

One of the radicals L and E is preferably Cyc, Phe or Pyr. E is preferably Cyc, Phe or Phe-Cyc. The media according to the invention preferably comprise one or more components selected from the compounds of the formulae 1, 2, 3, 4 and 5 in which L and E are selected from the group consisting of Cyc, Phe and Pyr and simultaneously one or more components selected from the compounds of the formulae 1, 2, 3, 4 and 5 in which one of the radicals L and E is selected from the group consisting of Cyc, Phe, Py and Pyr and the other radical is selected from the group consisting of -Phe-Phe-, -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-, and optionally one or more components selected from the compounds of the formulae 1, 2, 3, 4 and 5 in which the radicals L and E are selected from the group consisting of -Phe-Cyc-, -Cyc-Cyc-, -G-Phe- and -G-Cyc-.

R′ and/or R″ each, independently of one another, denote alkyl, alkenyl, alkoxy, alkoxyalkyl, alkenyloxy or alkanoyloxy having up to 8 C atoms, —F, —Cl, —CN, —NCS or —(O) i CH 3-k F k , where i is 0 or 1 and k is 1, 2 or 3.

In a smaller sub-group of the compounds of the formulae 1, 2, 3, 4 and 5, R′ and R″ each, independently of one another, denote alkyl, alkenyl, alkoxy, alkoxyalkyl, alkenyloxy or alkanoyloxy having up to 8 C atoms. This smaller sub-group is called group A below, and the compounds are referred to by the sub-formulae 1a, 2a, 3a, 4a and 5a. In most of these compounds, R′ and R″ are different from one another, one of these radicals usually being alkyl, alkenyl, alkoxy or alkoxyalkyl.

In another smaller sub-group of the compounds of the formulae 1, 2, 3, 4 and 5, which is referred to as group B, R″ denotes —F, —Cl, —NCS or —(O) i CH 3-k F k , where i is 0 or 1 and k is 1, 2 or 3. The compounds in which R″ has this meaning are referred to by the sub-formulae 1b, 2b, 3b, 4b and 5b. Particular preference is given to those compounds of the sub-formulae 1b, 2b, 3b, 4b and 5b in which R″ has the meaning —F, —Cl, —NCS, —CF 3 , —OCHF 2 or —OCF 3 .

In the compounds of the sub-formulae 1b, 2b, 3b, 4b and 5b, R′ has the meanings indicated in the case of the compounds of the sub-formulae 1a to 5a and is preferably alkyl, alkenyl, alkoxy or alkoxyalkyl.

In a further smaller sub-group of the compounds of the formulae 1, 2, 3, 4 and 5, R″ denotes —CN. This sub-group is referred to below as group C, and the compounds of this sub-group are correspondingly described by sub-formulae 1c, 2c, 3c, 4c and 5c. In the compounds of the sub-formulae 1c, 2c, 3c, 4c and 5c, R′ has the meanings indicated in the case of the compounds of the sub-formulae 1a to 5a and is preferably alkyl, alkoxy or alkenyl.

Besides the preferred compounds of groups A, B and C, other compounds of the formulae 1, 2, 3, 4 and 5 having other variants of the proposed substituents are also customary. All these substances are obtainable by methods which are known from the literature or analogously thereto.

Besides compounds of the formula I according to the invention, the media according to the invention preferably comprise one or more compounds selected from groups A, B and/or C. The proportions by weight of the compounds from these groups in the media according to the invention are preferably:

group A: 0 to 90%, preferably 20 to 90%, particularly preferably 30 to 90%; group B: 0 to 80%, preferably 10 to 80%, particularly preferably 10 to 65%; group C: 0 to 80%, preferably 0 to 80%, particularly preferably 0 to 50%;

where the sum of the proportions by weight of the group A, B and/or C compounds present in the respective media according to the invention is preferably 5 to 90% and particularly preferably 10 to 90%.

›The media according to the invention preferably comprise…

The media according to the invention preferably comprise 1 to 40%, particularly preferably 5 to 30%, of the compounds according to the invention.

The liquid-crystal mixtures according to the invention are prepared in a manner which is conventional per se. In general, the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, preferably at elevated temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and to remove the solvent again, for example by distillation, after thorough mixing. It is furthermore possible to prepare the mixtures in other conventional manners, for example by using premixes, for example homologue mixtures, or using so-called “multibottle” systems.

The dielectrics may also comprise further additives known to the person skilled in the art and described in the literature. For example, 0 to 15%, preferably 0 to 10%, of pleochroic dyes, chiral dopants, stabilisers or nanoparticles can be added. The individual compounds added are employed in concentrations of 0.01 to 6%, preferably 0.1 to 3%. However, the concentration data of the other constituents of the liquid-crystal mixtures, i.e. the liquid-crystalline or mesogenic compounds are given here without taking into account the concentration of these additives.

The liquid-crystal mixtures according to the invention enable a significant broadening of the available parameter latitude.

The invention also relates to electro-optical displays (in particular TFT displays having two plane-parallel outer plates, which, together with a frame, form a cell, integrated non-linear elements for switching individual pixels on the outer plates, and a nematic liquid-crystal mixture having positive dielectric anisotropy and high specific resistance located in the cell) which contain media of this type, and to the use of these media for electro-optical purposes.

The term “alkyl” encompasses straight-chain and branched alkyl groups having 1-9 carbon atoms, in particular the straight-chain groups methyl, ethyl, propyl, butyl, pentyl, hexyl and heptyl. Groups having 2-5 carbon atoms are generally preferred.

The term “alkenyl” encompasses straight-chain and branched alkenyl groups having up to 9 carbon atoms, in particular the straight-chain groups. Particularly preferred alkenyl groups are C 2 -C 7 -1E-alkenyl, C 4 -C 7 -3E-alkenyl, C 5 -C 7 -4-alkenyl, C 6 -C 7 -5-alkenyl and C 7 -6-alkenyl, in particular C 2 -C 7 -1E-alkenyl, C 4 -C 7 -3E-alkenyl and C 5 -C 7 -4-alkenyl. Examples of preferred alkenyl groups are vinyl, 1E-propenyl, 1E-butenyl, 1E-pentenyl, 1E-hexenyl, 1E-heptenyl, 3-butenyl, 3E-pentenyl, 3E-hexenyl, 3E-heptenyl, 4-pentenyl, 4Z-hexenyl, 4E-hexenyl, 4Z-heptenyl, 5-hexenyl, 6-heptenyl and the like. Groups having up to 5 carbon atoms are generally preferred.

The term “halogenated alkyl radical” preferably encompasses mono- or polyfluorinated and/or chlorinated radicals. Perhalogenated radicals are included. Particular preference is given to fluorinated alkyl radicals, in particular CF 3 , CH 2 CF 3 , CH 2 CHF 2 , CHF 2 , CH 2 F, CHFCF 3 and CF 2 CHFCF 3 .

The total amount of compounds of the formula I in the mixtures according to the invention is not crucial. The mixtures may therefore comprise one or more further components for the purposes of optimisation of various properties. However, the observed effect on the response times and the threshold voltage is generally greater, the higher the total concentration of compounds of the formulae I to XV.

The construction of the matrix display according to the invention from polarisers, electrode base plates and surface-treated electrodes corresponds to the usual design for displays of this type. The term usual design is broadly drawn here and also encompasses all derivatives and modifications of the matrix display, in particular also matrix display elements based on poly-Si TFTs.

A significant difference between the displays according to the invention and the hitherto conventional ones based on the twisted nematic cell consists, however, in the choice of the liquid-crystal parameters of the liquid-crystal layer.

The following examples are intended to explain the invention without restricting it. Above and below, percentage data denote percent by weight. All temperatures are indicated in degrees Celsius. Furthermore, C=crystalline state, N=nematic phase, S=smectic phase and I=isotropic phase. The data between these symbols represent the transition temperatures. Δn denotes optical anisotropy (589 nm, 20° C.), Δ∈ the dielectric anisotropy (1 kHz, 20° C.) and γ 1 the rotational viscosity (in the unit mPa·s).

The physical, physicochemical and electro-optical parameters are determined by generally known methods, as described, inter alia, in the brochure “Merck Liquid Crystals—Licristal®—Physical Properties of Liquid Crystals—Description of the Measurement Methods”, 1998, Merck KGaA, Darmstadt.

The dielectric anisotropy Δ∈ of the individual substances is determined at 20° C. and 1 kHz. To this end, 5-10% by weight of the substance to be investigated are measured dissolved in the dielectrically positive mixture ZLI-4792 (Merck KGaA), and the measurement value is extrapolated to a concentration of 100%. The optical anisotropy Δn is determined at 20° C. and a wavelength of 589.3 nm, the rotational viscosity γ 1 at 20° C., both likewise by linear extrapolation.

EXAMPLE 1
›Step 1.1

A solution of 62.1 g (160 mmol) of the bromide 2 in 300 ml of THF is added at 20° C. under nitrogen to 96 ml (190 mmol) of a 2 M solution of isopropylmagnesium chloride in THF. After 1 h, 29.0 g (190 mmol) of the ketone 1, dissolved in 200 ml of THF, are added, likewise at 20° C. After a further hour, the batch is hydrolysed using 250 ml of water, acidified using 1 N hydrochloric acid and diluted with 500 ml of heptane. The aqueous phase is extracted with MTB ether. The combined organic phases are washed with sat. sodium hydrogencarbonate solution, dried over sodium sulfate and evaporated. The substance 3 is employed in the subsequent step without further purification.

›Step 1.2

68.1 g (130 mmol) of the alcohol 1 are dissolved in 400 ml of toluene, and 1.1 g (10 mmol) of p-toluenesulfonic acid monohydrate are added, and the mixture is heated on a water separator for 2 h. The solvent is subsequently removed, and the residue obtained is passed over silica gel with toluene. Crystallisation from ethanol and n-heptane.

C 63 N 155 I

Δ∈ 21

Δn 0.132

The following compounds of the formula

are prepared analogously:

EXAMPLE 2
›Step 2.1

Analogously to Example 1, step 1.1, the cyclohexane ketone 5 is reacted with the bromide 2, which has previously been metallated. The substance 6 is employed in the subsequent step without further purification.

›Step 2.2

Analogously to Example 1, step 1.2, the intermediate 6 from step 2.1 is eliminated using p-TsOH to give the cyclohexene 7. The solvent is subsequently removed, and the residue obtained is passed over silica gel with toluene. Crystallisation from ethanol and n-heptane.

C 56 N 121 I

Δ∈ 27

Δn 0.123

The compounds are formed as diastereomer mixtures of the two trans-isomers on the tetrahydropyran (about 1:1, HPLC). Unless indicated otherwise, the values apply to the diastereomer mixtures formed.

The following compounds of the formula

are prepared analogously:

EXAMPLE 3
›Step 3.1

The α-fluorinated ketone 6 is prepared by the method of S. Stavber, M. Zupan, Tetrahedron Lett. 1996, 37, 3591-3594, by reaction with 1-fluoro-4-hydroxy-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (Accufluor™ NFTh) in acetonitrile. The fluoroketone 6 is converted, analogously to M. A. Hoosain, Tetrahedron Lett. 1997, 38, 49-52, into the enol triflate 7 using trifluorosulfonic anhydride.

The boronic acid 9 can be prepared from building block 2 (cf. Example 1), isopropylmagnesium chloride and trimethyl borate with subsequent acidic hydrolysis.

›Step 3.2

Under nitrogen, 24.5 g (74 mmol) of sodium metaborate octahydrate are initially introduced in 30 ml of water, and 30 ml of THF, 700 ml of bis(triphenylphosphine)palladium(II) chloride and 0.1 ml of 80% hydrazinium hydroxide are added. After 5 minutes, 14.5 g (50 mmol) of the triflate 8 and 17.7 g (50 mmol) of the boronic acid 9 as well as a further 30 ml of THF are added. The batch is refluxed for 6 h. The cooled mixture is diluted with 100 ml of MTB ether. The organic phase is evaporated, and the residue is purified on silica gel (toluene). Crystallisation from ethanol and n-heptane.

The following compounds of the formula

are prepared analogously:

EXAMPLE 4
›Step 4.1

A solution of 62.1 g (160 mmol) of the bromide 2 in 300 ml of THF is added at 20° C. under nitrogen to 96 ml (190 mmol) of a 2 M solution of isopropylmagnesium chloride in THF. After 1 h, 190 mmol of the ketone 11, dissolved in 200 ml of THF, are added, likewise at 20° C. The work-up is carried out analogously to step 1.1. Substance 12 is employed in the subsequent step without further purification.

›Step 4.2

The reaction and purification are carried out analogously to step 1.2.

C 22 I

Δ∈ 21

Δn 0.095

γ 1 68 mPa·s

The following compounds of the formula

where L 3 =F are prepared analogously to Example 4:

Compounds where L 3 =L 4 =H are preferably prepared in accordance with Example 5:

EXAMPLE 5
›Step 5.1

Under nitrogen, 15.0 g (40 mmol) of the bromide 2 are dissolved in 110 ml of dioxane, and 16.2 g (60 mmol) of bis(pinacolato)diboron are added. 12.5 g (130 mmol) of potassium acetate and 950 mg of PdCl 2 -dppf (dppf: 1,1′-bis(diphenylphosphanyl)ferrocene) are subsequently added. The batch is stirred at 100° C. for 4 h. The cooled batch is diluted with 100 ml of MTB ether, and 70 ml of water are added. The aqueous phase is extracted with MTB ether. The combined organic phases are washed with water and saturated sodium chloride solution, dried and evaporated. The residue is crystallised from ethanol at −30° C.

›Step 5.2

14.5 g of sodium metaborate octahydrate in 20 ml of water are initially introduced, and 490 mg of bis(triphenylphosphine)palladium(II) chloride, 30 ml of THF and hydrazinium hydroxide are added. After 5 min, 9.6 g (30 mmol) of the triflate 15 and 14.0 g of the boronic ester 14 are added to the batch. After 15 h at 70° C., the batch is diluted with water. The aqueous phase is extracted with MTB ether. The combined organic phases are evaporated. The residue is filtered through silica gel (n-heptane) and subsequently crystallised from ethanol and from n-heptane.

C 62 N (24) I

Δ∈15

Δn 0.122

γ 1 79 mPa·s

The following compounds of the formula

where L 3 , L 4 =H are prepared analogously to Example 5:

EXAMPLE 6
›Step 6.1

The reaction is carried out analogously to Example 4, step 4.1.

›Step 6.2

The reaction and purification are carried out analogously to step 1.2.

›Step 6.3

The boronic acid is prepared as second starting material for the subsequent step analogously to compound 14 from Example 5, step 5.1.

›Step 6.4

The reaction and purification are carried out using bis(tricyclohexylphosphine)palladium(II) chloride, aqueous base (Na 2 CO 3 ) in the water/toluene two-phase system as described, for example, in the publication IDE 4340490 A1. The work-up and purification are carried out analogously to step 5.2.

C 65 SmA (63) N 145 I

Δ∈ 24

Δn 0.190

The following compounds of the formula

are prepared analogously to Example 6:

EXAMPLE 7
›Step 7.1

180 ml (290 mmol) of 15% BuLi in n-hexane are added at −70° C. under nitrogen to a solution of the pyridine (50.0 g; 260 mmol) in 400 ml of diethyl ether. After 60 min, a solution of 36.4 g (260 mmol) of the cyclohexyl ketone in 200 ml of diethyl ether is added to the batch, likewise at low temperature. After a further hour, the batch is warmed to −20° C. and added to ice-water. The organic phase is dried over sodium sulfate and evaporated. The residue obtained is employed in the subsequent step without further purification.

›Step 7.2

Under nitrogen, 66 g (260.0 mmol) of the alcohol derivative are dissolved in 800 ml of dichloromethane and 108 ml of triethylamine, and 26.2 ml (340 mmol) of methanesulfonyl chloride (MsCl) are added at 0° C. The batch is stirred overnight at RT. The reaction mixture is subsequently added to water and extracted with MTB ether. The organic phase is evaporated, and the residue obtained is passed over silica gel (MTB ether/n-heptane 1:4). The residue is employed in the subsequent step without further purification.

›Step 7.3

8.7 g (30 mmol) of sodium metaborate octahydrate are initially introduced in 15 ml of water, and 40 ml of THF, 0.10 ml of hydrazinium hydroxide and 300 mg of bis(triphenylphosphine)palladium(II) chloride are added, and the mixture is stirred at RT for 5 min. A solution of 21.5 g (35%; 20 mmol) of the boronic acid derivative and 4.7 g (20 mmol) of the pyridine chloride is subsequently added to the batch. After 15 h under reflux, the reaction mixture is extracted with MTB ether. The organic phase is evaporated. The residue is filtered through silica gel (n-heptane). The final purification of the product is carried out by crystallisation from heptane.

C 73 SmA (73) N 138 I

Δ∈ 30

Δn 0.197

The following is prepared analogously:

C 100 SmC 107 SmA 184 N 195 I

Δ∈ 24

Δn 0.215

›EXAMPLE 8

The corresponding dioxane compounds are prepared analogously to the compounds from Example 2.

C 84 N 121 I

Δ∈ 34

Δn 0.123.

Further combinations of the embodiments and variants of the invention in accordance with the description arise from the following claims.

›Tables in the description — 9
in which one or more hydrogen atoms may be substituted by F, CN, SCN, SF S , CH 2 F, CHF 2 , CF 3 , OCH 2 F, OCHF 2 or OCF 3 ,one or more double bonds may be replaced by single bonds, M, M 1 or M 2 denotes —O—, —S—, —CH 2 —, —CHY— or —CYY 1 — in such a way that adjacent groups do not simultaneously denote —O— or —S—, andY and Y 1 denote Cl, F, CN, OCF 3 or CF 3 ,
V denotes H or F,Z 1 , Z 2 and Z 3 each, independently of one another, identically or differently, denote a single bond, —CH 2 O—, —(CO)O—, —CF 2 O—, —CH 2 CH 2 CF 2 O—, —CF 2 CF 2 —, —CH 2 CF 2 —, —CH 2 CH 2 —, —(CH 2 ) 4 —, —CH═CH—, —CH═CF—, —CF═CF— or —C≡C—, where asymmetrical bridges may be oriented to both sides, anda denotes 0, 1 or 2, preferably 0 or 1,b denotes 1 or 2, preferably 1, andc denotes 0, 1 or 2, preferably 0,
in which Z 2 , Z 3 , A 2 , A 3 , A 4 , b, c and R 2 are as defined in Claim 1 , andHal denotes Cl or Br.The alcohol formed after work-up is preferably eliminated to give a cyclohexene compound of the formula I. This is preferably achieved by addition of a catalytic amount of acid, in particular p-toluenesulfonic acid (p-TsOH).b) A process for the preparation of compounds of the formula I according to Claim 1 in which V denotes hydrogen or fluorine comprising a process step, characterised in that a cyclohexane of the formula
in which R 1 , A 1 , Z 1 , V and a are as defined in Claim 1 ,is reacted with a boronic acid or an open-chain or cyclic boronic acid ester of the formulae
in which Z 2 , Z 3 , A 2 , A 3 , A 4 , b, c and R 2 are as defined in Claim 1 , andR 3 , R 4 denote alkyl having 1-12 C atoms or R 3 +R 4 together also denote an alkylene, in particular of the formulae
The following abbreviations are used:
p-TsOHp-toluenesulfonic acid
THFtetrahydrofuran
MTB ethermethyl t-butyl ether
R 1XL 1L 2L 3L 4Values
HFHHHH
CH 3FHHHH
C 2 H 5FHHHH
C 3 H 7FHHHH
n-C 4 H 9FHHHH
n-C 5 H 11FHHHH
n-C 6 H 13FHHHH
HFFHHH
CH 3FFHHH
C 2 H 5FFHHH
n-C 3 H 7FFHHHC 56 Sm 81 SmB 105 N 207
I; Δε 12; Δn 0.155
n-C 4 H 9FFHHH
n-C 5 H 11FFHHH
n-C 6 H 13FFHHH
HFFFHH
CH 3FFFHH
C 2 H 5FFFHH
n-C 3 H 7FFFHHC 81 N 183 I; Δε 16; Δn 0.148
n-C 4 H 9FFFHH
n-C 5 H 11FFFHH
n-C 6 H 13FFFHH
HOCF 3HHHH
CH 3OCF 3HHHH
C 2 H 5OCF 3HHHH
n-C 3 H 7OCF 3HHHH
n-C 4 H 9OCF 3HHHH
n-C 5 H 11OCF 3HHHH
n-C 6 H 13OCF 3HHHH
HOCF 3FHHH
CH 3OCF 3FHHH
C 2 H 5OCF 3FHHH
n-C 3 H 7OCF 3FHHHC 59 Sm 117 SmB 127 SmC
129 N 209 I; Δε 14; Δn 0.150
n-C 4 H 9OCF 3FHHH
n-C 5 H 11OCF 3FHHH
n-C 6 H 13OCF 3FHHH
HOCF 3FFHH
CH 3OCF 3FFHH
C 2 H 5OCF 3FFHH
n-C 3 H 7OCF 3FFHHC 58 SmB 76 N 191 I;
Δε 16; Δn 0.142
n-C 4 H 9OCF 3FFHH
n-C 5 H 11OCF 3FFHH
n-C 6 H 13OCF 3FFHH
HCNHHHH
CH 3CNHHHH
C 2 H 5CNHHHH
n-C 3 H 7CNHHHH
n-C 4 H 9CNHHHH
n-C 5 H 11CNHHHH
n-C 6 H 13CNHHHH
HCNFHHH
CH 3CNFHHH
C 2 H 5CNFHHH
n-C 3 H 7CNFHHH
n-C 4 H 9CNFHHH
n-C 5 H 11CNFHHH
n-C 6 H 13CNFHHH
HCNFFHH
CH 3CNFFHH
C 2 H 5CNFFHH
n-C 3 H 7CNFFHH
n-C 4 H 9CNFFHH
n-C 5 H 11CNFFHH
n-C 6 H 13CNFFHH
HFHHFH
CH 3FHHFH
C 2 H 5FHHFH
C 3 H 7FHHFH
n-C 4 H 9FHHFH
n-C 5 H 11FHHFH
n-C 6 H 13FHHFH
HFFHFH
CH 3FFHFH
C 2 H 5FFHFH
n-C 3 H 7FFHFH
n-C 4 H 9FFHFH
n-C 5 H 11FFHFH
n-C 6 H 13FFHFH
HFFFFH
CH 3FFFFH
C 2 H 5FFFFH
n-C 3 H 7FFFFH
n-C 4 H 9FFFFH
n-C 5 H 11FFFFH
n-C 6 H 13FFFFH
HOCF 3HHFH
CH 3OCF 3HHFH
C 2 H 5OCF 3HHFH
n-C 3 H 7OCF 3HHFH
n-C 4 H 9OCF 3HHFH
n-C 5 H 11OCF 3HHFH
n-C 6 H 13OCF 3HHFH
HOCF 3FHFH
CH 3OCF 3FHFH
C 2 H 5OCF 3FHFH
n-C 3 H 7OCF 3FHFH
n-C 4 H 9OCF 3FHFH
n-C 5 H 11OCF 3FHFH
n-C 6 H 13OCF 3FHFH
HOCF 3FFFH
CH 3OCF 3FFFH
C 2 H 5OCF 3FFFH
n-C 3 H 7OCF 3FFFH
n-C 4 H 9OCF 3FFFH
n-C 5 H 11OCF 3FFFH
n-C 6 H 13OCF 3FFFH
HCNHHFH
CH 3CNHHFH
C 2 H 5CNHHFH
n-C 3 H 7CNHHFH
n-C 4 H 9CNHHFH
n-C 5 H 11CNHHFH
n-C 6 H 13CNHHFH
HCNFHFH
CH 3CNFHFH
C 2 H 5CNFHFH
n-C 3 H 7CNFHFH
n-C 4 H 9CNFHFH
n-C 5 H 11CNFHFH
n-C 6 H 13CNFHFH
HCNFFFH
CH 3CNFFFH
C 2 H 5CNFFFH
n-C 3 H 7CNFFFH
n-C 4 H 9CNFFFH
n-C 5 H 11CNFFFH
n-C 6 H 13CNFFFH
HFHHFF
CH 3FHHFF
C 2 H 5FHHFF
n-C 4 H 9FHHFF
n-C 5 H 11FHHFF
n-C 6 H 13FHHFF
HFFHFF
CH 3FFHFF
C 2 H 5FFHFF
n-C 3 H 7FFHFF
n-C 4 H 9FFHFF
n-C 5 H 11FFHFF
n-C 6 H 13FFHFF
HFFFFF
CH 3FFFFF
—CH═CH 2FFFFF
C 2 H 5FFFFFC 57 N 131 I; Δε 22;
Δn 0.124; γ 1 367 mPa · s
n-C 3 H 7FFFFFcf. Example 1
n-C 4 H 9FFFFFC 65 N 150 I; Δε 21;
Δn 0.124
n-C 5 H 11FFFFFC 71 N 156 I; Δε 20;
Δn 0.133
n-C 6 H 13FFFFF
n-C 7 H 15FFFFF
HOCF 3HHFF
CH 3OCF 3HHFF
C 2 H 5OCF 3HHFF
n-C 3 H 7OCF 3HHFF
n-C 4 H 9OCF 3HHFF
n-C 5 H 11OCF 3HHFF
n-C 6 H 13OCF 3HHFF
HOCF 3FHFF
CH 3OCF 3FHFF
C 2 H 5OCF 3FHFF
n-C 3 H 7OCF 3FHFF
n-C 4 H 9OCF 3FHFF
n-C 5 H 11OCF 3FHFF
n-C 6 H 13OCF 3FHFF
HOCF 3FFFF
CH 3OCF 3FFFF
C 2 H 5OCF 3FFFF
n-C 3 H 7OCF 3FFFF
n-C 4 H 9OCF 3FFFF
n-C 5 H 11OCF 3FFFF
n-C 6 H 13OCF 3FFFF
HCNHHFF
CH 3CNHHFF
C 2 H 5CNHHFF
n-C 3 H 7CNHHFF
n-C 4 H 9CNHHFF
n-C 5 H 11CNHHFF
n-C 6 H 13CNHHFF
HCNFHFF
CH 3CNFHFF
C 2 H 5CNFHFF
n-C 3 H 7CNFHFF
n-C 4 H 9CNFHFF
n-C 5 H 11CNFHFF
n-C 6 H 13CNFHFF
HCNFFFF
CH 3CNFFFF
C 2 H 5CNFFFF
n-C 3 H 7CNFFFF
n-C 4 H 9CNFFFF
n-C 5 H 11CNFFFF
n-C 6 H 13CNFFFF
n-C 7 H 15CNFFFF
R 1XL 1L 2L 3L 4Values
HFHHFF
CH 3FHHFF
C 2 H 5FHHFF
n-C 4 H 9FHHFF
n-C 5 H 11FHHFF
n-C 6 H 13FHHFF
HFFHFF
CH 3FFHFF
C 2 H 5FFHFF
n-C 3 H 7FFHFF
n-C 4 H 9FFHFF
n-C 5 H 11FFHFF
n-C 6 H 13FFHFF
HFFFFF
CH 3FFFFF
C 2 H 5FFFFFC 66 N 96 I; Δε 27; Δn 0.120
n-C 3 H 7FFFFFcf. Example 2
n-C 4 H 9FFFFFC 32 N 116 I; Δε 26;
Δn 0.118
n-C 5 H 11FFFFFC 62 N 119 I; Δε 25;
Δn 0.123
n-C 6 H 13FFFFF
n-C 7 H 15FFFFF
HOCF 3HHFF
CH 3OCF 3HHFF
C 2 H 5OCF 3HHFF
n-C 4 H 9OCF 3HHFF
n-C 5 H 11OCF 3HHFF
n-C 6 H 13OCF 3HHFF
HOCF 3FHFF
CH 3OCF 3FHFF
C 2 H 5OCF 3FHFF
n-C 3 H 7OCF 3FHFFC 5 SmA 110 N 143 I; Δε 22;
Δn 0.125
n-C 4 H 9OCF 3FHFF
n-C 5 H 11OCF 3FHFF
n-C 6 H 13OCF 3FHFF
HOCF 3FFFF
CH 3OCF 3FFFF
C 2 H 5OCF 3FFFF
n-C 3 H 7OCF 3FFFFC 43 SmA 105 N 144 I;
Δε 23; Δn 0.129
n-C 4 H 9OCF 3FFFF
n-C 5 H 11OCF 3FFFF
n-C 6 H 13OCF 3FFFF
n-C 7 H 15OCF 3FFFF
HFHHHH
CH 3FHHHH
C 2 H 5FHHHH
n-C 4 H 9FHHHH
n-C 5 H 11FHHHH
n-C 6 H 13FHHHH
HFFHHH
CH 3FFHHH
C 2 H 5FFHHH
n-C 3 H 7FFHHHC 44 SmB 142 SmA 179 N
187 I; Δε 18; Δn 0.142
n-C 4 H 9FFHHH
n-C 5 H 11FFHHH
n-C 6 H 13FFHHH
HFFFHH
CH 3FFFHH
C 2 H 5FFFHH
n-C 3 H 7FFFHHC 68 SmB 108 SmA 114 N
161 I; Δε 20; Δn 0.140
n-C 4 H 9FFFHH
n-C 5 H 11FFFHH
n-C 6 H 13FFFHH
n-C 7 H 15FFFHH
HOCF 3HHHH
CH 3OCF 3HHHH
C 2 H 5OCF 3HHHH
n-C 4 H 9OCF 3HHHH
n-C 5 H 11OCF 3HHHH
n-C 6 H 13OCF 3HHHH
HOCF 3FHHH
CH 3OCF 3FHHH
C 2 H 5OCF 3FHHH
n-C 3 H 7OCF 3FHHH
n-C 4 H 9OCF 3FHHH
n-C 5 H 11OCF 3FHHH
n-C 6 H 13OCF 3FHHH
HOCF 3FFHH
CH 3OCF 3FFHH
C 2 H 5OCF 3FFHH
n-C 3 H 7OCF 3FFHHC 57 SmB 95 SmA 134 N
169 I; Δε 22; Δn 0.138
n-C 4 H 9OCF 3FFHH
n-C 5 H 11OCF 3FFHH
n-C 6 H 13OCF 3FFHH
n-C 7 H 15OCF 3FFHH
R 1XL 1L 2L 3L 4
HFHHHH
CH 3FHHHH
C 2 H 5FHHHH
C 3 H 7FHHHH
n-C 4 H 9FHHHH
n-C 5 H 11FHHHH
n-C 6 H 13FHHHH
HFFHHH
CH 3FFHHH
C 2 H 5FFHHH
n-C 3 H 7FFHHH
n-C 4 H 9FFHHH
n-C 5 H 11FFHHH
n-C 6 H 13FFHHH
HFFFHH
CH 3FFFHH
n-C 4 H 9FFFHH
n-C 5 H 11FFFHH
n-C 6 H 13FFFHH
HOCF 3HHHH
CH 3OCF 3HHHH
C 2 H 5OCF 3HHHH
n-C 3 H 7OCF 3HHHH
n-C 4 H 9OCF 3HHHH
n-C 5 H 11OCF 3HHHH
n-C 6 H 13OCF 3HHHH
HOCF 3FHHH
CH 3OCF 3FHHH
C 2 H 5OCF 3FHHH
n-C 3 H 7OCF 3FHHH
n-C 4 H 9OCF 3FHHH
n-C 5 H 11OCF 3FHHH
n-C 6 H 13OCF 3FHHH
HOCF 3FFHH
CH 3OCF 3FFHH
C 2 H 5OCF 3FFHH
n-C 3 H 7OCF 3FFHH
n-C 4 H 9OCF 3FFHH
n-C 5 H 11OCF 3FFHH
n-C 6 H 13OCF 3FFHH
HCNHHHH
CH 3CNHHHH
C 2 H 5CNHHHH
n-C 3 H 7CNHHHH
n-C 4 H 9CNHHHH
n-C 5 H 11CNHHHH
n-C 6 H 13CNHHHH
HCNFHHH
CH 3CNFHHH
C 2 H 5CNFHHH
n-C 3 H 7CNFHHH
n-C 4 H 9CNFHHH
n-C 5 H 11CNFHHH
n-C 6 H 13CNFHHH
HCNFFHH
CH 3CNFFHH
C 2 H 5CNFFHH
n-C 3 H 7CNFFHH
n-C 4 H 9CNFFHH
n-C 5 H 11CNFFHH
n-C 6 H 13CNFFHH
HFHHFH
CH 3FHHFH
C 2 H 5FHHFH
C 3 H 7FHHFH
n-C 4 H 9FHHFH
n-C 5 H 11FHHFH
n-C 6 H 13FHHFH
HFFHFH
CH 3FFHFH
C 2 H 5FFHFH
n-C 3 H 7FFHFH
n-C 4 H 9FFHFH
n-C 5 H 11FFHFH
n-C 6 H 13FFHFH
HFFFFH
CH 3FFFFH
C 2 H 5FFFFH
n-C 3 H 7FFFFH
n-C 4 H 9FFFFH
n-C 5 H 11FFFFH
n-C 6 H 13FFFFH
HOCF 3HHFH
CH 3OCF 3HHFH
C 2 H 5OCF 3HHFH
n-C 3 H 7OCF 3HHFH
n-C 4 H 9OCF 3HHFH
n-C 5 H 11OCF 3HHFH
n-C 6 H 13OCF 3HHFH
HOCF 3FHFH
CH 3OCF 3FHFH
C 2 H 5OCF 3FHFH
n-C 3 H 7OCF 3FHFH
n-C 4 H 9OCF 3FHFH
n-C 5 H 11OCF 3FHFH
n-C 6 H 13OCF 3FHFH
HOCF 3FFFH
CH 3OCF 3FFFH
C 2 H 5OCF 3FFFH
n-C 3 H 7OCF 3FFFH
n-C 4 H 9OCF 3FFFH
n-C 5 H 11OCF 3FFFH
n-C 6 H 13OCF 3FFFH
HCNHHFH
CH 3CNHHFH
C 2 H 5CNHHFH
n-C 3 H 7CNHHFH
n-C 4 H 9CNHHFH
n-C 5 H 11CNHHFH
n-C 6 H 13CNHHFH
HCNFHFH
CH 3CNFHFH
C 2 H 5CNFHFH
n-C 3 H 7CNFHFH
n-C 4 H 9CNFHFH
n-C 5 H 11CNFHFH
n-C 6 H 13CNFHFH
HCNFFFH
CH 3CNFFFH
C 2 H 5CNFFFH
n-C 3 H 7CNFFFH
n-C 4 H 9CNFFFH
n-C 5 H 11CNFFFH
n-C 6 H 13CNFFFH
HFHHFF
CH 3FHHFF
C 2 H 5FHHFF
n-C 4 H 9FHHFF
n-C 5 H 11FHHFF
n-C 6 H 13FHHFF
HFFHFF
CH 3FFHFF
C 2 H 5FFHFF
n-C 3 H 7FFHFF
n-C 4 H 9FFHFF
n-C 5 H 11FFHFF
n-C 6 H 13FFHFF
HFFFFF
CH 3FFFFF
C 2 H 5FFFFF
C 2 H 5FFFFF
n-C 3 H 7FFFFF
n-C 4 H 9FFFFF
n-C 5 H 11FFFFF
n-C 6 H 13FFFFF
HOCF 3HHFF
CH 3OCF 3HHFF
C 2 H 5OCF 3HHFF
n-C 3 H 7OCF 3HHFF
n-C 4 H 9OCF 3HHFF
n-C 5 H 11OCF 3HHFF
n-C 6 H 13OCF 3HHFF
HOCF 3FHFF
CH 3OCF 3FHFF
C 2 H 5OCF 3FHFF
n-C 3 H 7OCF 3FHFF
n-C 4 H 9OCF 3FHFF
n-C 5 H 11OCF 3FHFF
n-C 6 H 13OCF 3FHFF
HOCF 3FFFF
CH 3OCF 3FFFF
C 2 H 5OCF 3FFFF
n-C 3 H 7OCF 3FFFF
n-C 4 H 9OCF 3FFFF
n-C 5 H 11OCF 3FFFF
n-C 6 H 13OCF 3FFFF
HCNHHFF
CH 3CNHHFF
C 2 H 5CNHHFF
n-C 3 H 7CNHHFF
n-C 4 H 9CNHHFF
n-C 5 H 11CNHHFF
n-C 6 H 13CNHHFF
HCNFHFF
CH 3CNFHFF
C 2 H 5CNFHFF
n-C 3 H 7CNFHFF
n-C 4 H 9CNFHFF
n-C 5 H 11CNFHFF
n-C 6 H 13CNFHFF
HCNFFFF
CH 3CNFFFF
C 2 H 5CNFFFF
n-C 3 H 7CNFFFF
n-C 4 H 9CNFFFF
n-C 5 H 11CNFFFF
n-C 6 H 13CNFFFF
R 1XL 1L 2L 3L 4Values
HFHHFH
CH 3FHHFH
C 2 H 5FHHFH
C 3 H 7FHHFH
n-C 4 H 9FHHFH
n-C 5 H 11FHHFH
n-C 6 H 13FHHFH
HFFHFH
CH 3FFHFH
C 2 H 5FFHFH
n-C 3 H 7FFHFHC 28 N (−7) I; Δε 17;
Δn 0.106; γ 1 112 mPa · s
n-C 4 H 9FFHFH
n-C 5 H 11FFHFH
n-C 6 H 13FFHFH
HFFFFH
CH 3FFFFH
C 2 H 5FFFFH
n-C 3 H 7FFFFHC 28 N (−7) I; Δε 17;
Δn 0.106; γ 1 112 mPa · s
n-C 4 H 9FFFFH
n-C 5 H 11FFFFH
n-C 6 H 13FFFFH
HOCF 3HHFH
CH 3OCF 3HHFH
C 2 H 5OCF 3HHFH
C 3 H 7OCF 3HHFH
n-C 4 H 9OCF 3HHFH
n-C 5 H 11OCF 3HHFH
n-C 6 H 13OCF 3HHFH
HOCF 3FHFH
CH 3OCF 3FHFH
C 2 H 5OCF 3FHFH
n-C 3 H 7OCF 3FHFH
n-C 4 H 9OCF 3FHFH
n-C 5 H 11OCF 3FHFH
n-C 6 H 13OCF 3FHFH
HOCF 3FFFH
CH 3OCF 3FFFH
C 2 H 5OCF 3FFFH
n-C 3 H 7OCF 3FFFH
n-C 4 H 9OCF 3FFFH
n-C 5 H 11OCF 3FFFH
n-C 6 H 13OCF 3FFFH
HClHHFH
CH 3ClHHFH
C 2 H 5ClHHFH
C 3 H 7ClHHFH
n-C 4 H 9ClHHFH
n-C 5 H 11ClHHFH
n-C 6 H 13ClHHFH
HClFHFH
CH 3ClFHFH
C 2 H 5ClFHFH
n-C 3 H 7ClFHFH
n-C 4 H 9ClFHFH
n-C 5 H 11ClFHFH
n-C 6 H 13ClFHFH
HClFFFH
CH 3ClFFFH
C 2 H 5ClFFFH
n-C 3 H 7ClFFFH
n-C 4 H 9ClFFFH
n-C 5 H 11ClFFFH
n-C 6 H 13ClFFFH
HOCHF 2HHFH
CH 3OCHF 2HHFH
C 2 H 5OCHF 2HHFH
n-C 3 H 7OCHF 2HHFH
n-C 4 H 9OCHF 2HHFH
n-C 5 H 11OCHF 2HHFH
n-C 6 H 13OCHF 2HHFH
HOCHF 2FHFH
CH 3OCHF 2FHFH
C 2 H 5OCHF 2FHFH
n-C 3 H 7OCHF 2FHFH
n-C 4 H 9OCHF 2FHFH
n-C 5 H 11OCHF 2FHFH
n-C 6 H 13OCHF 2FHFH
HOCHF 2FFFH
CH 3OCHF 2FFFH
C 2 H 5OCHF 2FFFH
n-C 3 H 7OCHF 2FFFH
n-C 4 H 9OCHF 2FFFH
n-C 5 H 11OCHF 2FFFH
n-C 6 H 13OCHF 2FFFH
HOCHFCF 3HHFH
CH 3OCHFCF 3HHFH
C 2 H 5OCHFCF 3HHFH
n-C 3 H 7OCHFCF 3HHFH
n-C 4 H 9OCHFCF 3HHFH
n-C 5 H 11OCHFCF 3HHFH
n-C 6 H 13OCHFCF 3HHFH
HOCHFCF 3FHFH
CH 3OCHFCF 3FHFH
C 2 H 5OCHFCF 3FHFH
n-C 3 H 7OCHFCF 3FHFH
n-C 4 H 9OCHFCF 3FHFH
n-C 5 H 11OCHFCF 3FHFH
n-C 6 H 13OCHFCF 3FHFH
HOCHFCF 3FFFH
CH 3OCHFCF 3FFFH
C 2 H 5OCHFCF 3FFFH
n-C 3 H 7OCHFCF 3FFFH
n-C 4 H 9OCHFCF 3FFFH
n-C 5 H 11OCHFCF 3FFFH
n-C 6 H 13OCHFCF 3FFFH
HOCHFCF 3HHFH
CH 3OCHFCF 3HHFH
C 2 H 5OCHFCF 3HHFH
n-C 3 H 7OCHFCF 3HHFH
n-C 4 H 9OCHFCF 3HHFH
n-C 5 H 11OCHFCF 3HHFH
n-C 6 H 13OCHFCF 3HHFH
HOCHFCF 3FHFH
CH 3OCHFCF 3FHFH
C 2 H 5OCHFCF 3FHFH
n-C 3 H 7OCHFCF 3FHFH
n-C 4 H 9OCHFCF 3FHFH
n-C 5 H 11OCHFCF 3FHFH
n-C 6 H 13OCHFCF 3FHFH
HOCHFCF 3FFFH
CH 3OCHFCF 3FFFH
C 2 H 5OCHFCF 3FFFH
n-C 3 H 7OCHFCF 3FFFH
n-C 4 H 9OCHFCF 3FFFH
n-C 5 H 11OCHFCF 3FFFH
n-C 6 H 13OCHFCF 3FFFH
HNCSHHFH
CH 3NCSHHFH
C 2 H 5NCSHHFH
n-C 3 H 7NCSHHFH
n-C 4 H 9NCSHHFH
n-C 5 H 11NCSHHFH
n-C 6 H 13NCSHHFH
HNCSFHFH
CH 3NCSFHFH
C 2 H 5NCSFHFH
n-C 3 H 7NCSFHFH
n-C 4 H 9NCSFHFH
n-C 5 H 11NCSFHFH
n-C 6 H 13NCSFHFH
HNCSFFFH
CH 3NCSFFFH
C 2 H 5NCSFFFH
n-C 3 H 7NCSFFFH
n-C 4 H 9NCSFFFH
n-C 5 H 11NCSFFFH
n-C 6 H 13NCSFFFH
n-C 6 H 13C 3 H 7FFFH
HSF 5HHFH
CH 3SF 5HHFH
C 2 H 5SF 5HHFH
n-C 3 H 7SF 5HHFH
n-C 4 H 9SF 5HHFH
n-C 5 H 11SF 5HHFH
n-C 6 H 13SF 5HHFH
HSF 5FHFH
CH 3SF 5FHFH
C 2 H 5SF 5FHFH
n-C 3 H 7SF 5FHFH
n-C 4 H 9SF 5FHFH
n-C 5 H 11SF 5FHFH
n-C 6 H 13SF 5FHFH
HSF 5FFFH
CH 3SF 5FFFH
C 2 H 5SF 5FFFH
n-C 3 H 7SF 5FFFH
n-C 4 H 9SF 5FFFH
n-C 5 H 11SF 5FFFH
n-C 6 H 13SF 5FFFH
HCNHHFH
CH 3CNHHFH
C 2 H 5CNHHFH
n-C 3 H 7CNHHFH
n-C 4 H 9CNHHFH
n-C 5 H 11CNHHFH
n-C 6 H 13CNHHFH
HCNFHFH
CH 3CNFHFH
C 2 H 5CNFHFH
n-C 3 H 7CNFHFH
n-C 4 H 9CNFHFH
n-C 5 H 11CNFHFH
n-C 6 H 13CNFHFH
HCNFFFH
CH 3CNFFFH
C 2 H 5CNFFFH
n-C 3 H 7CNFFFH
n-C 4 H 9CNFFFH
n-C 5 H 11CNFFFH
n-C 6 H 13CNFFFH
HFHHFF
CH 3FHHFF
C 2 H 5FHHFF
n-C 4 H 9FHHFF
n-C 5 H 11FHHFF
n-C 6 H 13FHHFF
HFFHFF
CH 3FFHFF
C 2 H 5FFHFF
n-C 3 H 7FFHFF
n-C 4 H 9FFHFF
n-C 5 H 11FFHFF
n-C 6 H 13FFHFF
HFFFFF
CH 3FFFFF
—CH═CH 2FFFFF
C 2 H 5FFFFFΔε 19; Δn 0.080;
γ 1 58 mPa · s
n-C 3 H 7FFFFFcf. Example 4
n-C 4 H 9FFFFFΔε 20; Δn 0.082;
γ 1 76 mPa · s
n-C 5 H 11FFFFFΔε 19; Δn 0.085;
γ 1 115 mPa · s
n-C 6 H 13FFFFF
n-C 7 H 15FFFFF
HOCF 3HHFF
CH 3OCF 3HHFF
C 2 H 5OCF 3HHFF
n-C 4 H 9OCF 3HHFF
n-C 5 H 11OCF 3HHFF
n-C 6 H 13OCF 3HHFF
HOCF 3FHFF
CH 3OCF 3FHFF
C 2 H 5OCF 3FHFF
n-C 3 H 7OCF 3FHFF
n-C 4 H 9OCF 3FHFF
n-C 5 H 11OCF 3FHFF
n-C 6 H 13OCF 3FHFF
HOCF 3FFFF
CH 3OCF 3FFFF
—CH═CH 2OCF 3FFFF
C 2 H 5OCF 3FFFF
n-C 3 H 7OCF 3FFFF
n-C 4 H 9OCF 3FFFF
n-C 5 H 11OCF 3FFFF
n-C 6 H 13OCF 3FFFF
n-C 7 H 15OCF 3FFFF
HClHHFF
CH 3ClHHFF
C 2 H 5ClHHFF
C 3 H 7ClHHFFC 49 N (44) I; Δε 13;
Δn 0.140; γ 1 164 mPa · s
n-C 4 H 9ClHHFF
n-C 5 H 11ClHHFF
n-C 6 H 13ClHHFF
HClFHFF
CH 3ClFHFF
C 2 H 5ClFHFF
n-C 3 H 7ClFHFFC 38 N (23) I; Δε 16;
Δn 0.128; γ 1 141 mPa · s
n-C 4 H 9ClFHFF
n-C 5 H 11ClFHFF
n-C 6 H 13ClFHFF
HClFFFF
CH 3ClFFFF
C 2 H 5ClFFFF
n-C 3 H 7ClFFFF
n-C 4 H 9ClFFFF
n-C 5 H 11ClFFFF
n-C 6 H 13ClFFFF
HCNHHFF
CH 3CNHHFF
C 2 H 5CNHHFF
n-C 3 H 7CNHHFF
n-C 4 H 9CNHHFF
n-C 5 H 11CNHHFF
n-C 6 H 13CNHHFF
HCNFHFF
CH 3CNFHFF
C 2 H 5CNFHFF
n-C 3 H 7CNFHFF
n-C 4 H 9CNFHFF
n-C 5 H 11CNFHFF
n-C 6 H 13CNFHFF
HCNFFFF
CH 3CNFFFF
C 2 H 5CNFFFF
n-C 3 H 7CNFFFF
n-C 4 H 9CNFFFF
n-C 5 H 11CNFFFF
n-C 6 H 13CNFFFF
n-C 7 H 15CNFFFF
R 1XL 1L 2L 3L 4Values
HFHHHH
CH 3FHHHH
C 2 H 5FHHHH
C 3 H 7FHHHH
n-C 4 H 9FHHHH
n-C 5 H 11FHHHH
n-C 6 H 13FHHHH
HFFHHH
CH 3FFHHH
C 2 H 5FFHHH
n-C 3 H 7FFHHH
n-C 4 H 9FFHHH
n-C 5 H 11FFHHH
n-C 6 H 13FFHHH
HFFFHH
CH 3FFFHH
C 2 H 5FFFHH
n-C 3 H 7FFFHHcf. Example 5
n-C 4 H 9FFFHH
n-C 5 H 11FFFHH
n-C 6 H 13FFFHH
HOCF 3HHHH
CH 3OCF 3HHHH
C 2 H 5OCF 3HHHH
n-C 3 H 7OCF 3HHHH
n-C 4 H 9OCF 3HHHH
n-C 5 H 11OCF 3HHHH
n-C 6 H 13OCF 3HHHH
HOCF 3FHHH
CH 3OCF 3FHHH
C 2 H 5OCF 3FHHH
n-C 3 H 7OCF 3FHHH
n-C 4 H 9OCF 3FHHH
n-C 5 H 11OCF 3FHHH
n-C 6 H 13OCF 3FHHH
HOCF 3FFHH
CH 3OCF 3FFHH
C 2 H 5OCF 3FFHH
n-C 3 H 7OCF 3FFHH
n-C 4 H 9OCF 3FFHH
n-C 5 H 11OCF 3FFHH
n-C 6 H 13OCF 3FFHH
HCNHHHH
CH 3CNHHHH
C 2 H 5CNHHHH
n-C 3 H 7CNHHHH
n-C 4 H 9CNHHHH
n-C 5 H 11CNHHHH
n-C 6 H 13CNHHHH
HCNFHHH
CH 3CNFHHH
C 2 H 5CNFHHH
n-C 3 H 7CNFHHH
n-C 4 H 9CNFHHH
n-C 5 H 11CNFHHH
n-C 6 H 13CNFHHH
HCNFFHH
CH 3CNFFHH
C 2 H 5CNFFHH
n-C 3 H 7CNFFHH
n-C 4 H 9CNFFHH
n-C 5 H 11CNFFHH
n-C 6 H 13CNFFHH
R 1XL 1L 2L 3L 4L 5L 6Values
HFHHHHHH
CH 3FHHHHHH
C 2 H 5FHHHHHH
C 3 H 7FHHHHHH
n-C 4 H 9FHHHHHH
n-C 5 H 11FHHHHHH
n-C 6 H 13FHHHHHH
HFFHHHHH
CH 3FFHHHHH
C 2 H 5FFHHHHH
n-C 3 H 7FFHHHHH
n-C 4 H 9FFHHHHH
n-C 5 H 11FFHHHHH
n-C 6 H 13FFHHHHH
HFFFHHHH
CH 3FFFHHHH
C 2 H 5FFFHHHH
n-C 3 H 7FFFHHHHC 105 SmE 129 SmC′
134 SmC 150 SmA 169
N 193 I; Δε 19; Δn 0.211
n-C 4 H 9FFFHHHH
n-C 5 H 11FFFHHHH
n-C 6 H 13FFFHHHH
HFHHFHHH
CH 3FHHFHHH
C 2 H 5FHHFHHH
C 3 H 7FHHFHHH
n-C 4 H 9FHHFHHH
n-C 5 H 11FHHFHHH
n-C 6 H 13FHHFHHH
HFFHFHHH
CH 3FFHFHHH
C 2 H 5FFHFHHH
n-C 3 H 7FFHFHHH
n-C 4 H 9FFHFHHH
n-C 5 H 11FFHFHHH
n-C 6 H 13FFHFHHH
HFFFFHHH
CH 3FFFFHHH
C 2 H 5FFFFHHH
n-C 3 H 7FFFFHHH
n-C 4 H 9FFFFHHH
n-C 5 H 11FFFFHHH
n-C 6 H 13FFFFHHH
HFHHFFHH
CH 3FHHFFHH
C 2 H 5FHHFFHH
C 3 H 7FHHFFHH
n-C 4 H 9FHHFFHH
n-C 5 H 11FHHFFHH
n-C 6 H 13FHHFFHH
HFFHFFHH
CH 3FFHFFHH
C 2 H 5FFHFFHH
n-C 3 H 7FFHFFHH
n-C 4 H 9FFHFFHH
n-C 5 H 11FFHFFHH
n-C 6 H 13FFHFFHH
HFFFFFHH
CH 3FFFFFHH
C 2 H 5FFFFFHH
n-C 3 H 7FFFFFHHC 104 N 140 I;
Δε 25; Δn 0.197
n-C 4 H 9FFFFFHH
n-C 5 H 11FFFFFHH
n-C 6 H 13FFFFFHH
HFHHHHFH
CH 3FHHHHFH
C 2 H 5FHHHHFH
C 3 H 7FHHHHFH
n-C 4 H 9FHHHHFH
n-C 5 H 11FHHHHFH
n-C 6 H 13FHHHHFH
HFFHHHFH
CH 3FFHHHFH
C 2 H 5FFHHHFH
n-C 3 H 7FFHHHFH
n-C 4 H 9FFHHHFH
n-C 5 H 11FFHHHFH
n-C 6 H 13FFHHHFH
HFFFHHFH
CH 3FFFHHFH
C 2 H 5FFFHHFH
n-C 3 H 7FFFHHFHC 78 SmA 109 N 161 I;
Δε 22; Δn 0.203
n-C 4 H 9FFFHHFH
n-C 5 H 11FFFHHFH
n-C 6 H 13FFFHHFH
HFHHFHFH
CH 3FHHFHFH
C 2 H 5FHHFHFH
C 3 H 7FHHFHFH
n-C 4 H 9FHHFHFH
n-C 5 H 11FHHFHFH
n-C 6 H 13FHHFHFH
HFFHFHFH
CH 3FFHFHFH
C 2 H 5FFHFHFH
n-C 3 H 7FFHFHFH
n-C 4 H 9FFHFHFH
n-C 5 H 11FFHFHFH
n-C 6 H 13FFHFHFH
HFFFFHFH
CH 3FFFFHFH
C 2 H 5FFFFHFH
n-C 3 H 7FFFFHFHcf. Example 6
n-C 4 H 9FFFFHFH
n-C 5 H 11FFFFHFH
n-C 6 H 13FFFFHFH
HFHHFFFH
CH 3FHHFFFH
C 2 H 5FHHFFFH
C 3 H 7FHHFFFH
n-C 4 H 9FHHFFFH
n-C 5 H 11FHHFFFH
n-C 6 H 13FHHFFFH
HFFHFFFH
CH 3FFHFFFH
C 2 H 5FFHFFFH
n-C 3 H 7FFHFFFH
n-C 4 H 9FFHFFFH
n-C 5 H 11FFHFFFH
n-C 6 H 13FFHFFFH
HFFFFFFH
CH 3FFFFFFH
C 2 H 5FFFFFFH
n-C 3 H 7FFFFFFHC 84 N 127 I;
Δε 29; Δn 0.183
n-C 4 H 9FFFFFFH
n-C 5 H 11FFFFFFH
n-C 6 H 13FFFFFFH
HFHHHHFF
CH 3FHHHHFF
C 2 H 5FHHHHFF
C 3 H 7FHHHHFF
n-C 4 H 9FHHHHFF
n-C 5 H 11FHHHHFF
n-C 6 H 13FHHHHFF
HFFHHHFF
CH 3FFHHHFF
C 2 H 5FFHHHFF
n-C 3 H 7FFHHHFF
n-C 4 H 9FFHHHFF
n-C 5 H 11FFHHHFF
n-C 6 H 13FFHHHFF
HFFFHHFF
CH 3FFFHHFF
C 2 H 5FFFHHFF
n-C 3 H 7FFFHHFFC 108 N 140 I;
Δε 26; Δn 0.187
n-C 4 H 9FFFHHFF
n-C 5 H 11FFFHHFF
n-C 6 H 13FFFHHFF
HFHHFHFF
CH 3FHHFHFF
C 2 H 5FHHFHFF
C 3 H 7FHHFHFF
n-C 4 H 9FHHFHFF
n-C 5 H 11FHHFHFF
n-C 6 H 13FHHFHFF
HFFHFHFF
CH 3FFHFHFF
C 2 H 5FFHFHFF
n-C 3 H 7FFHFHFF
n-C 4 H 9FFHFHFF
n-C 5 H 11FFHFHFF
n-C 6 H 13FFHFHFF
HFFFFHFF
CH 3FFFFHFF
C 2 H 5FFFFHFF
n-C 3 H 7FFFFHFFC 83 N 125 I; Δε 29;
Δn 0.177
n-C 4 H 9FFFFHFF
n-C 5 H 11FFFFHFF
n-C 6 H 13FFFFHFF
HFHHFFFF
CH 3FHHFFFF
C 2 H 5FHHFFFF
C 3 H 7FHHFFFF
n-C 4 H 9FHHFFFF
n-C 5 H 11FHHFFFF
n-C 6 H 13FHHFFFF
HFFHFFFF
CH 3FFHFFFF
C 2 H 5FFHFFFF
n-C 3 H 7FFHFFFF
n-C 4 H 9FFHFFFF
n-C 5 H 11FFHFFFF
n-C 6 H 13FFHFFFF
HFFFFFFF
CH 3FFFFFFF
C 2 H 5FFFFFFF
n-C 3 H 7FFFFFFFC 84 N 109 I; Δε 33;
Δn 0.168
n-C 4 H 9FFFFFFF
n-C 5 H 11FFFFFFF
n-C 6 H 13FFFFFFF
HOCF 3HHHHHH
CH 3OCF 3HHHHHH
C 2 H 5OCF 3HHHHHH
C 3 H 7OCF 3HHHHHH
n-C 4 H 9OCF 3HHHHHH
n-C 5 H 11OCF 3HHHHHH
n-C 6 H 13OCF 3HHHHHH
HOCF 3FHHHHH
CH 3OCF 3FHHHHH
C 2 H 5OCF 3FHHHHH
n-C 3 H 7OCF 3FHHHHHC 31 SmC′ 120 SmC
139 SmA′ 159 SmA 223
N 228 I; Δε 16; Δn 0.212
n-C 4 H 9OCF 3FHHHHH
n-C 5 H 11OCF 3FHHHHH
n-C 6 H 13OCF 3FHHHHH
HOCF 3FFHHHH
CH 3OCF 3FFHHHH
C 2 H 5OCF 3FFHHHH
n-C 3 H 7OCF 3FFHHHH
n-C 4 H 9OCF 3FFHHHH
n-C 5 H 11OCF 3FFHHHH
n-C 6 H 13OCF 3FFHHHH
HOCF 3HHFHHH
CH 3OCF 3HHFHHH
C 2 H 5OCF 3HHFHHH
C 3 H 7OCF 3HHFHHH
n-C 4 H 9OCF 3HHFHHH
n-C 5 H 11OCF 3HHFHHH
n-C 6 H 13OCF 3HHFHHH
HOCF 3FHFHHH
CH 3OCF 3FHFHHH
C 2 H 5OCF 3FHFHHH
n-C 3 H 7OCF 3FHFHHH
n-C 4 H 9OCF 3FHFHHH
n-C 5 H 11OCF 3FHFHHH
n-C 6 H 13OCF 3FHFHHH
HOCF 3FFFHHH
CH 3OCF 3FFFHHH
C 2 H 5OCF 3FFFHHH
n-C 3 H 7OCF 3FFFHHH
n-C 4 H 9OCF 3FFFHHH
n-C 5 H 11OCF 3FFFHHH
n-C 6 H 13OCF 3FFFHHH
HOCF 3HHFFHH
CH 3OCF 3HHFFHH
C 2 H 5OCF 3HHFFHH
C 3 H 7OCF 3HHFFHH
n-C 4 H 9OCF 3HHFFHH
n-C 5 H 11OCF 3HHFFHH
n-C 6 H 13OCF 3HHFFHH
HOCF 3FHFFHH
CH 3OCF 3FHFFHH
C 2 H 5OCF 3FHFFHH
n-C 3 H 7OCF 3FHFFHH
n-C 4 H 9OCF 3FHFFHH
n-C 5 H 11OCF 3FHFFHH
n-C 6 H 13OCF 3FHFFHH
HOCF 3FFFFHH
CH 3OCF 3FFFFHH
C 2 H 5OCF 3FFFFHH
n-C 3 H 7OCF 3FFFFHH
n-C 4 H 9OCF 3FFFFHH
n-C 5 H 11OCF 3FFFFHH
n-C 6 H 13OCF 3FFFFHH
HOCF 3HHHHFH
CH 3OCF 3HHHHFH
C 2 H 5OCF 3HHHHFH
C 3 H 7OCF 3HHHHFH
n-C 4 H 9OCF 3HHHHFH
n-C 5 H 11OCF 3HHHHFH
n-C 6 H 13OCF 3HHHHFH
HOCF 3FHHHFH
CH 3OCF 3FHHHFH
C 2 H 5OCF 3FHHHFH
n-C 3 H 7OCF 3FHHHFHC 31 SmA 177 N 193 I;
Δε 18; Δn 0.197
n-C 4 H 9OCF 3FHHHFH
n-C 5 H 11OCF 3FHHHFH
n-C 6 H 13OCF 3FHHHFH
HOCF 3FFHHFH
CH 3OCF 3FFHHFH
C 2 H 5OCF 3FFHHFH
n-C 3 H 7OCF 3FFHHFH
n-C 4 H 9OCF 3FFHHFH
n-C 5 H 11OCF 3FFHHFH
n-C 6 H 13OCF 3FFHHFH
HOCF 3HHFHFH
CH 3OCF 3HHFHFH
C 2 H 5OCF 3HHFHFH
C 3 H 7OCF 3HHFHFH
n-C 4 H 9OCF 3HHFHFH
n-C 5 H 11OCF 3HHFHFH
n-C 6 H 13OCF 3HHFHFH
HOCF 3FHFHFH
CH 3OCF 3FHFHFH
C 2 H 5OCF 3FHFHFH
n-C 3 H 7OCF 3FHFHFH
n-C 4 H 9OCF 3FHFHFH
n-C 5 H 11OCF 3FHFHFH
n-C 6 H 13OCF 3FHFHFH
HOCF 3FFFHFH
CH 3OCF 3FFFHFH
C 2 H 5OCF 3FFFHFH
n-C 3 H 7OCF 3FFFHFH
n-C 4 H 9OCF 3FFFHFH
n-C 5 H 11OCF 3FFFHFH
n-C 6 H 13OCF 3FFFHFH
HOCF 3HHFFFH
CH 3OCF 3HHFFFH
C 2 H 5OCF 3HHFFFH
C 3 H 7OCF 3HHFFFH
n-C 4 H 9OCF 3HHFFFH
n-C 5 H 11OCF 3HHFFFH
n-C 6 H 13OCF 3HHFFFH
HOCF 3FHFFFH
CH 3OCF 3FHFFFH
C 2 H 5OCF 3FHFFFH
n-C 3 H 7OCF 3FHFFFHC 57 SmA 125 N 153 I;
Δε 25; Δn 0.183
n-C 4 H 9OCF 3FHFFFH
n-C 5 H 11OCF 3FHFFFH
n-C 6 H 13OCF 3FHFFFH
HOCF 3FFFFFH
CH 3OCF 3FFFFFH
C 2 H 5OCF 3FFFFFH
n-C 3 H 7OCF 3FFFFFH
n-C 4 H 9OCF 3FFFFFH
n-C 5 H 11OCF 3FFFFFH
n-C 6 H 13OCF 3FFFFFH
HOCF 3HHHHFF
CH 3OCF 3HHHHFF
C 2 H 5OCF 3HHHHFF
C 3 H 7OCF 3HHHHFF
n-C 4 H 9OCF 3HHHHFF
n-C 5 H 11OCF 3HHHHFF
n-C 6 H 13OCF 3HHHHFF
HOCF 3FHHHFF
CH 3OCF 3FHHHFF
C 2 H 5OCF 3FHHHFF
n-C 3 H 7OCF 3FHHHFF
n-C 4 H 9OCF 3FHHHFF
n-C 5 H 11OCF 3FHHHFF
n-C 6 H 13OCF 3FHHHFF
HOCF 3FFHHFF
CH 3OCF 3FFHHFF
C 2 H 5OCF 3FFHHFF
n-C 3 H 7OCF 3FFHHFF
n-C 4 H 9OCF 3FFHHFF
n-C 5 H 11OCF 3FFHHFF
n-C 6 H 13OCF 3FFHHFF
HOCF 3HHFHFF
CH 3OCF 3HHFHFF
C 2 H 5OCF 3HHFHFF
C 3 H 7OCF 3HHFHFF
n-C 4 H 9OCF 3HHFHFF
n-C 5 H 11OCF 3HHFHFF
n-C 6 H 13OCF 3HHFHFF
HOCF 3FHFHFF
CH 3OCF 3FHFHFF
C 2 H 5OCF 3FHFHFF
n-C 3 H 7OCF 3FHFHFF
n-C 4 H 9OCF 3FHFHFF
n-C 5 H 11OCF 3FHFHFF
n-C 6 H 13OCF 3FHFHFF
HOCF 3FFFHFF
CH 3OCF 3FFFHFF
C 2 H 5OCF 3FFFHFF
n-C 3 H 7OCF 3FFFHFF
n-C 4 H 9OCF 3FFFHFF
n-C 5 H 11OCF 3FFFHFF
n-C 6 H 13OCF 3FFFHFF
HOCF 3HHFFFF
CH 3OCF 3HHFFFF
C 2 H 5OCF 3HHFFFF
C 3 H 7OCF 3HHFFFF
n-C 4 H 9OCF 3HHFFFF
n-C 5 H 11OCF 3HHFFFF
n-C 6 H 13OCF 3HHFFFF
HOCF 3FHFFFF
CH 3OCF 3FHFFFF
C 2 H 5OCF 3FHFFFF
n-C 3 H 7OCF 3FHFFFF
n-C 4 H 9OCF 3FHFFFF
n-C 5 H 11OCF 3FHFFFF
n-C 6 H 13OCF 3FHFFFF
HOCF 3FFFFFF
CH 3OCF 3FFFFFF
C 2 H 5OCF 3FFFFFF
n-C 3 H 7OCF 3FFFFFF
n-C 4 H 9OCF 3FFFFFF
n-C 5 H 11OCF 3FFFFFF
n-C 6 H 13OCF 3FFFFFF
4 of 29 part labels are ours — the grant heads the rest

Claims as granted

24 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

21 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C09K19/06
  • C09K19/32
  • C09K19/00
  • C09K19/52
USPC · US Patent Classification
252/299.6570/131252/299.64252/299.1252/299.67570/129252/299.63570/126570/127568/442570/130252/299.65430/20252/299.66252/299.62428/11252/299.61

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJul 2007Jan 2008Jul 2008Jan 2009Jul 2009Jan 2010Jul 2010Jan 2011Jul 2011Jan 2012Jul 2012USPTOApplicantNon-final rejectionNon-final rejectionNon-final rejectionNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
4.8 y
1,742 days filing → grant
Office actions
3
non-final + final
Responses
4
no RCE
Examiner
Geraldina Visconti
art unit 1722 · TC 1700
Citations: 17 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom2010201220142016201820202022202420262028Owner 1
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock